miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways.
Su W, Hong L, Xu X, Huang S, Herpai D, Li L, Xu Y, Truong L, Hu WY, Wu X, Xiao C, Zhang W, Han J, Debinski W, Xiang R, Sun P.
Su W, et al. Among authors: huang s.
Oncogene. 2018 Oct;37(42):5618-5632. doi: 10.1038/s41388-018-0358-1. Epub 2018 Jun 15.
Oncogene. 2018.
PMID: 29907771
Free PMC article.